Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leukine +/- Dexamethasone with Gemcitabine and 5-FU in Metastatic RCC
NCT00176280Phase 2Withdrawn
- Sponsor
- University of Kentucky
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, open-label trial of sargramostim in renal cell carcinoma (RCC), sponsored by University of Kentucky. Planned start Sep 2005; status: withdrawn.
02
Drugs
sargramostim
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00176280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176280.